1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
CIS PROLINE - PRO 48
Lubienski, M.J.
Bycroft, M.
Freund, S.M.V.
Fersht, A.R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
33
8866
8877
10.1021/bi00196a003
8043574
Three-dimensional solution structure and 13C assignments of barstar using nuclear magnetic resonance spectroscopy.
1994
NE
Trends Biochem.Sci.
TBSCDB
0946
0968-0004
14
450
Barnase and Barstar: Two Small Proteins to Fold and Fit Together
1989
10.2210/pdb1bta/pdb
pdb_00001bta
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
10221.543
BARSTAR
1
man
polymer
no
no
KKAVINGEQIRSISDLHQTLKKELALPEYYGENLDALWDCLTGWVEYPLVLEWRQFEQSKQLTENGAESVLQVFREAKAE
GCDITIILS
KKAVINGEQIRSISDLHQTLKKELALPEYYGENLDALWDCLTGWVEYPLVLEWRQFEQSKQLTENGAESVLQVFREAKAE
GCDITIILS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Bacillus
sample
1390
Bacillus amyloliquefaciens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1994-07-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1994-05-09
REL
1
BRUNGER
refinement
X-PLOR
LYS
1
n
1
LYS
1
A
LYS
2
n
2
LYS
2
A
ALA
3
n
3
ALA
3
A
VAL
4
n
4
VAL
4
A
ILE
5
n
5
ILE
5
A
ASN
6
n
6
ASN
6
A
GLY
7
n
7
GLY
7
A
GLU
8
n
8
GLU
8
A
GLN
9
n
9
GLN
9
A
ILE
10
n
10
ILE
10
A
ARG
11
n
11
ARG
11
A
SER
12
n
12
SER
12
A
ILE
13
n
13
ILE
13
A
SER
14
n
14
SER
14
A
ASP
15
n
15
ASP
15
A
LEU
16
n
16
LEU
16
A
HIS
17
n
17
HIS
17
A
GLN
18
n
18
GLN
18
A
THR
19
n
19
THR
19
A
LEU
20
n
20
LEU
20
A
LYS
21
n
21
LYS
21
A
LYS
22
n
22
LYS
22
A
GLU
23
n
23
GLU
23
A
LEU
24
n
24
LEU
24
A
ALA
25
n
25
ALA
25
A
LEU
26
n
26
LEU
26
A
PRO
27
n
27
PRO
27
A
GLU
28
n
28
GLU
28
A
TYR
29
n
29
TYR
29
A
TYR
30
n
30
TYR
30
A
GLY
31
n
31
GLY
31
A
GLU
32
n
32
GLU
32
A
ASN
33
n
33
ASN
33
A
LEU
34
n
34
LEU
34
A
ASP
35
n
35
ASP
35
A
ALA
36
n
36
ALA
36
A
LEU
37
n
37
LEU
37
A
TRP
38
n
38
TRP
38
A
ASP
39
n
39
ASP
39
A
CYS
40
n
40
CYS
40
A
LEU
41
n
41
LEU
41
A
THR
42
n
42
THR
42
A
GLY
43
n
43
GLY
43
A
TRP
44
n
44
TRP
44
A
VAL
45
n
45
VAL
45
A
GLU
46
n
46
GLU
46
A
TYR
47
n
47
TYR
47
A
PRO
48
n
48
PRO
48
A
LEU
49
n
49
LEU
49
A
VAL
50
n
50
VAL
50
A
LEU
51
n
51
LEU
51
A
GLU
52
n
52
GLU
52
A
TRP
53
n
53
TRP
53
A
ARG
54
n
54
ARG
54
A
GLN
55
n
55
GLN
55
A
PHE
56
n
56
PHE
56
A
GLU
57
n
57
GLU
57
A
GLN
58
n
58
GLN
58
A
SER
59
n
59
SER
59
A
LYS
60
n
60
LYS
60
A
GLN
61
n
61
GLN
61
A
LEU
62
n
62
LEU
62
A
THR
63
n
63
THR
63
A
GLU
64
n
64
GLU
64
A
ASN
65
n
65
ASN
65
A
GLY
66
n
66
GLY
66
A
ALA
67
n
67
ALA
67
A
GLU
68
n
68
GLU
68
A
SER
69
n
69
SER
69
A
VAL
70
n
70
VAL
70
A
LEU
71
n
71
LEU
71
A
GLN
72
n
72
GLN
72
A
VAL
73
n
73
VAL
73
A
PHE
74
n
74
PHE
74
A
ARG
75
n
75
ARG
75
A
GLU
76
n
76
GLU
76
A
ALA
77
n
77
ALA
77
A
LYS
78
n
78
LYS
78
A
ALA
79
n
79
ALA
79
A
GLU
80
n
80
GLU
80
A
GLY
81
n
81
GLY
81
A
CYS
82
n
82
CYS
82
A
ASP
83
n
83
ASP
83
A
ILE
84
n
84
ILE
84
A
THR
85
n
85
THR
85
A
ILE
86
n
86
ILE
86
A
ILE
87
n
87
ILE
87
A
LEU
88
n
88
LEU
88
A
SER
89
n
89
SER
89
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
11
0.173
SIDE CHAIN
1
A
ARG
54
0.309
SIDE CHAIN
1
A
ARG
75
0.108
SIDE CHAIN
1
A
PRO
27
-57.36
-179.66
1
A
TYR
30
-38.41
105.85
1
A
GLU
32
50.07
3.60
1
A
TRP
44
177.13
-66.63
1
A
LEU
62
-33.51
-32.03
1
A
GLU
64
-12.37
106.99
1
A
ASN
65
73.69
32.13
1
A
ASP
83
-109.29
65.33
1
A
THR
85
-52.92
98.90
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
THREE-DIMENSIONAL SOLUTION STRUCTURE AND 13C ASSIGNMENTS OF BARSTAR USING NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
1
Y
N
A
SER
14
A
SER
14
HELX_P
A
ALA
25
A
ALA
25
1
H1
12
A
ASN
33
A
ASN
33
HELX_P
A
GLY
43
A
GLY
43
1
H2
11
A
PHE
56
A
PHE
56
HELX_P
A
THR
63
A
THR
63
1
H3
8
A
GLU
68
A
GLU
68
HELX_P
A
GLY
81
A
GLY
81
1
H4
14
RIBONUCLEASE INHIBITOR
RIBONUCLEASE INHIBITOR
A
TYR
47
A
TYR
47
1
A
PRO
48
A
PRO
48
0.92
BARS_BACAM
UNP
1
1
P11540
KKAVINGEQIRSISDLHQTLKKELALPEYYGENLDALWDCLTGWVEYPLVLEWRQFEQSKQLTENGAESVLQVFREAKAE
GCDITIILS
1
89
1BTA
1
89
P11540
A
1
1
89
3
parallel
parallel
A
LYS
1
A
LYS
1
A
ASN
6
A
ASN
6
A
LEU
49
A
LEU
49
A
ARG
54
A
ARG
54
A
ASP
83
A
ASP
83
A
SER
89
A
SER
89
1
P 1